Infant glycogen storage disease type Ⅳ: a clinicopathological and genetic characteristics analysis of five cases.
10.3760/cma.j.cn112151-20230727-00032
- Author:
Q Y WANG
1
;
J S WANG
2
;
L CHEN
3
Author Information
1. Department of Pathology, Chidren's Hospital of Shanghai, Chidren's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200062, China.
2. Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai 201102, China.
3. Department of Pathology, Children's Hospital of Fudan University, Shanghai 201102, China.
- Publication Type:Journal Article
- MeSH:
Infant;
Child;
Humans;
Male;
Female;
Glycogen Storage Disease Type IV/pathology*;
Retrospective Studies;
China;
Mutation;
Genetic Testing/methods*
- From:
Chinese Journal of Pathology
2023;52(12):1255-1260
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical pathology and gene mutation characteristics of patients with glycogen storage disease type Ⅳ (GSD Ⅳ). Methods: The clinical data, liver histopathology and ultrastructural morphology, and gene sequencing results of 5 GSD Ⅳ cases diagnosed in the Children's Hospital Affiliated to Shanghai Jiaotong University School of Medicine and the Children's Hospital of Fudan University from January 2015 to February 2022 were collected and analyzed retrospectively. Results: Among the 5 cases, 3 were male and 2 were female, ranging in age from 4 months to 1 year and 9 months. The clinical manifestations included fever, hepatosplenomegaly, liver insufficiency, growth retardation and hypotonia. Four cases had liver biopsy showing ground-glass-like changes in hepatocytes with intracytoplasmic inclusion bodies and varying degrees of fibrosis. Liver electron microscopy in 2 cases showed that the level of glycogen increased to varying degrees, and the cytoplasm was filled with low electron density substances. Genetic testing revealed that 3 cases had compound heterozygous variants in GBE1 gene; 1 case had a single pathogenic variant in GBE1 gene; and 1 case was deceased with no genetic testing, but each parent was tested for a heterozygous variant in the GBE1 gene. A total of 9 GBE1 gene mutations were detected, 3 of which were reported mutations and 6 novel mutations. One case died of liver cirrhosis, and 1 case underwent autologous liver transplantation. After transplantation, the liver function basically returned to normal, and the growth and development improved; the other 3 cases were managed through diet control and symptomatic treatment. Conclusions: CSD Ⅳ is an extremely rare inherited metabolic disease caused by GBE1 gene mutation, often presenting with hepatic and neuromuscular disorders, with heterogeneous clinical manifestations. The diagnosis mainly depends on histopathology and a pedigree gene analysis.
